1. Clinically significant, nontraumatic, degenerative joint disease of the temporomandibular joints in a horse. (13th June 2015) Authors: Smyth, T.; Allen, A. L.; Carmalt, J. L. Journal: Equine veterinary education Issue: Volume 29:Number 2(2017) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). (23rd June 2022) Authors: Manavalan, J. S.; Pal, I.; Pursley, A.; Ward, G.; Smyth, T.; Sims, M.; Feith, D.; Loughran, T. P.; O'Connor, O. A.; Marchi, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. (23rd June 2022) Authors: Sims, M.; Ward, G.; Zhang, Z.; Jueliger, S.; Davis, M.; Boxall, A.; Taylor, J.; Biondo, A.; Lyons, J.; Smyth, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models. (October 2022) Authors: Hindley, C.; Biondo, A.; Brothwood, J.; Dao, K.H.; Kandola, N.; Lyons, J.; Nakatsuru, Y.; Smyth, T.; Wagner, S.; Wallis, N.; Hearn, K. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models. (October 2020) Authors: Smyth, T.; Brothwood, J.; Fazal, L.; Hearn, K.; Hindley, C.; Johnson, C.; Jones, M.; Kandola, N.; Lyons, J.; Martins, V.; Miyadera, K.; Muench, S.; Munck, J.; Nakatsuru, Y.; Ochiiwa, H.; Saini, H.; Shah, A.; Wagner, S.; Wilsher, N.; Wallis, N. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The non-peptidomimetic cIAP1/2 and XIAP antagonist ASTX660 promotes an anti-tumour immune response in T-cell lymphoma. (October 2020) Authors: Ferrari, N.; Ward, G.; Gewinner, C.; Jueliger, S.; Smyth, T.; Munck, J.; Davis, M.; Ferraldeschi, R.; Lyons, J.; Sims, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of potent small molecule allosteric inhibitors of SHP2. (October 2020) Authors: Hearn, K.; Berdini, V.; Chessari, G.; Davies, T.G.; Day, J.E.H.; Hamlett, C.; Hiscock, S.; Martins, V.; Muench, S.; Nakatsuru, Y.; Ochiiwa, H.; Price, A.; Rich, S.; Shah, A.; Shibata, Y.; Shimamura, T.; Smyth, T.; Wallis, N.G.; Wilsher, N.E.; Johnson, C.N. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Swimmers' Ears. Issue 5928 (17th August 1974) Authors: Smyth, T. Journal: BMJ Issue: Volume 3:Issue 5928(1974) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗